Lv520
1440 积分 2024-06-14 加入
Engineered receptors for soluble cellular communication and disease sensing
1天前
已完结
CD27-Armored BCMA CAR T Cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
18天前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
2个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
3个月前
已完结
The BTLA–HVEM axis restricts CAR T cell efficacy in cancer
5个月前
已完结
皖公网安备34019202002308
